Shattuck Labs, Inc. (NASDAQ: STTK) general counsel Erin Ator Thomson sold 5,000 shares of the company in a transaction that took place on Wednesday, April 28. The stock was sold for an average price of $ 35.00, for a total value of $ 175,000.00. Following the closing of the sale, the General Counsel now owns 95,259 shares of the company, valued at approximately $ 3,334,065. The transaction was disclosed in a filing with the SEC, available through the SEC website.
Erin Ator Thomson also recently completed the following trade (s):
- On Thursday, April 15, Erin Ator Thomson sold 7,000 shares of Shattuck Labs. The stock was sold for an average price of $ 30.77, for a total value of $ 215,390.00.
NASDAQ STTK open at $ 37.68 on Mondays. The company’s 50-day simple moving average is $ 31.77 and its 200-day simple moving average is $ 36.86. Shattuck Labs, Inc. has a 12 month low of $ 17.51 and a 12 month high of $ 60.52.
Shattuck Labs (NASDAQ: STTK) last released its results on Sunday, March 14. The company reported earnings per share ($ 0.31) for the quarter, beating the Zacks consensus estimate of ($ 0.39) by $ 0.08. The company reported sales of $ 1.34 million in the quarter. As a group, research analysts predict that Shattuck Labs, Inc. will post earnings per share of -1.82 for the current fiscal year.
A number of institutional investors have recently changed their holdings in the company. Pacer Advisors Inc. purchased a new stake in Shattuck Labs during the first quarter valued at approximately $ 25,000. Citigroup Inc. purchased a new equity stake in Shattuck Labs during the fourth quarter valued at approximately $ 130,000. Strs Ohio purchased a new equity stake in Shattuck Labs during the fourth quarter valued at approximately $ 167,000. Alliancebernstein LP purchased a new equity stake in Shattuck Labs during the fourth quarter valued at approximately $ 204,000. Finally, Credit Suisse AG purchased a new stake in shares of Shattuck Labs during the fourth quarter valued at approximately $ 209,000.
A number of equity analysts have commented on the company. Citigroup raised its price target on Shattuck Labs from $ 36.00 to $ 75.00 in a research note on Wednesday, January 20. Berenberg Bank launched a cover on Shattuck Labs shares in a report on Tuesday, April 20. They issued a “buy” note and a price target of $ 47.00 for the company. Zacks investment research to cut Shattuck Labs shares from a “hold” note to a “sell” note in a Saturday, March 20 report. Finally, Evercore ISI assumed coverage of Shattuck Labs shares in a research report on Monday, January 11. They set an “outperformance” rating for the company. One analyst rated the stock with a sell rating and six gave the company’s stock a buy rating. The company currently has a “Buy” consensus rating and an average price target of $ 45.60.
Shattuck Labs Company Profile
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune diseases in the United States. The Company’s lead product candidate is SL-172154, which is in a Phase 1 clinical trial for the treatment of ovarian, fallopian tube and peritoneal cancers.
Recommended Story: What Is The Definition Of Arbitration?
This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured article: Moving Average Convergence Divergence (MACD)
7 lithium stocks that will fuel the electric vehicle boom
The demand for lithium is expected to increase exponentially over the next several years. In fact, according to Statista, demand for lithium could very well double to 820,000 tonnes during this period. Some of that demand will come from companies that make the batteries we use every day. For example, lithium is an essential component of the batteries that power our mobile devices.
But the real growth will come as the United States fully embarks on electric vehicles (EVs). The Biden administration recently announced its intention to convert the US government’s fleet of more than 600,000 vehicles to electric vehicles.
And as you know, EV stocks are in a kind of bubble right now. Part of the reason is the growing number of companies that went public last year. However, as investors are starting to realize, not all of these companies will be the next Tesla. In fact, some of these companies may never succeed in bringing an electric vehicle to market, at least not on the scale that will be required.
Those who make it will need lithium and a lot of it. To help you browse the best lithium stocks to buy, we’ve prepared this special overview.
See “7 lithium stocks that will fuel the electric vehicle boom”.